Device / Technology News

RSS

BD Saf-T-Intima Safety Integrated IV Catheter System gets European approval for subcutaneous infusion therapy

BD (Becton, Dickinson and Company), a leading global medical technology company, announces the approval of the BD Saf-T-Intima Safety Integrated IV Catheter System for use in subcutaneous infusion therapies in Europe.

From BD (Becton, Dickinson and Company) 23 Jul 2013

MUCMD Symposium to be held at The Saban Research Institute of Children's Hospital Los Angeles

On August 16 and 17, the 3rd annual Meaningful Use of Complex Medical Data Symposium is returning to The Saban Research Institute of Children's Hospital Los Angeles.

23 Jul 2013

NYCEDC declares Innovate Health Tech NYC winners

New York City Economic Development Corporation today announced the winners of Innovate Health Tech NYC, a competition designed to promote innovation within New York City's health technology sector.

23 Jul 2013

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Presently, it is a diagnosis of exclusion. Patients end up spending, according to what’s been published in the medical literature, as many as 3 - 5 years going from doctor to doctor seeking a diagnosis because they tend to have nonspecific symptoms of a subjective nature.

23 Jul 2013

Novaliq receives CE mark approval for EyeSol technology

Novaliq GmbH, a drug delivery company with a focus on the topical application of ophthalmic technologies for poorly soluble drugs, today announced the successful CE mark approval for the first topical eye lubricant based on Novaliq's proprietary technology EyeSol.

23 Jul 2013

New version of RaySearch's RayStation treatment planning system released for clinical use

RaySearch Laboratories AB announces that version 4.0 of RaySearch's RayStation treatment planning system has been released for clinical use in several European countries, USA, Japan, Australia and New Zealand, and is scheduled for market release in Canada, China, and South Korea.

23 Jul 2013

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.

23 Jul 2013

Great Lakes NeuroTechnologies receives patent for Parkinson’s disease monitoring technology

Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during sleep to treat movement disorder symptoms.

22 Jul 2013

Fujikura to exercise option to license Cellmid’s midkine diagnostic technology

Cellmid Limited has received confirmation that Fujikura Kasei Co Ltd (Fujikura) will exercise its Option to licence the midkine (MK) diagnostic technology by paying the requisite JPY40 million (AUD 440,000) Milestone Fee.

22 Jul 2013

HistoGenetics selects MiSeq sequencing system from Illumina for use in CLIA laboratory

Illumina, Inc. today announced that HistoGenetics, the leader in high-resolution sequence-based human leukocyte antigen testing services, has selected the MiSeq sequencing system for use in its CLIA laboratory.

From Illumina, Inc. 22 Jul 2013

Toshiba, Unfors RaySafe partner to improve clinical staff safety during interventional procedures

To improve clinical staff safety during interventional procedures and help monitor radiation dose, Toshiba America Medical Systems, Inc. has partnered with Unfors RaySafe, Inc. to offer a new dose monitoring and management tool for Infinix-i cardiovascular X-ray systems. The Unfors RaySafe i2 displays real-time dose exposure information, helping to make exams safer for all clinical staff.

22 Jul 2013

Cochlear implants restore usable hearing to deaf patients

Cochlear implants, electrical prosthetic devices that stimulate inner ear neurons of individuals who have lost their cochlear sensory cells, restore usable hearing to deaf patients. Cochlear implant electrodes are placed in the fluid-filled scala tympani of the cochlea, at a significant distance from the spiral ganglion and even from the spiral ganglion dendrites.

22 Jul 2013

EHR enables physicians to assist patients faster, help combat vaccine-preventable diseases

Using an Electronic Health Record system to automate the immunization data shared between health providers and public health agencies enables physicians to assist individual patients faster and more effectively, while also providing more immediate, cohesive community data to the agencies tasked with promoting public health.

20 Jul 2013

Kala Pharmaceuticals to present preclinical data on mucosal-penetrating particle technology

Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Kala researchers will present preclinical data at the upcoming Controlled Release Society (CRS) 2013 Annual Meeting taking place July 21-24, 2013, in Honolulu, HI.

20 Jul 2013

CETSA helps scientists determine effectiveness of drugs in the body

The search for new drugs, including those for cancer, is set to speed up thanks to a new research technique invented by scientists at the Nanyang Technological University.

20 Jul 2013

HealthTrust renews contract with McKesson Automation for pharmacy automation solutions

HealthTrust, a group purchasing and total cost management solutions company representing more than 1,400 acute-care facilities, has renewed its contract with McKesson Automation, ensuring that its member hospitals and health systems have continued access to a full portfolio of central pharmacy and point-of-care pharmacy automation solutions and services.

20 Jul 2013

Cook Medical launches Biodesign ENT Repair Graft for rhinologists

Cook Medical launched a new treatment option today for rhinologists (nose and sinus specialists) who treat patients that suffer from difficult-to-heal conditions in the nasal passages. The Biodesign ENT Repair Graft, which acts as an adjunct to aid in the natural healing process following nasal and sinus mucosal surgery, was introduced at the American Rhinologic Society's 2013 Summer Sinus Symposium. It is the latest Biodesign offering from Cook Medical's Otolaryngology-Head and Neck Surgery clinical division.

20 Jul 2013

Boston Scientific initiates OPTIMISE trial to study ONS using Precision System for chronic migraine

Boston Scientific Corporation has launched a clinical trial to determine whether occipital nerve stimulation using the Precision System can safely and effectively treat chronic migraine when used in conjunction with anti-migraine medications.

20 Jul 2013

Pi2 Solutions introduces Drug Safety Triager application in UK

Pi2 Solutions introduces its Drug Safety Triager application to a wide UK audience of Drug Safety and Medical Information professionals at the 8th Annual Conference of the Pharmaceutical Information and Pharmacovigilance Association in Chesham, England.

20 Jul 2013

Mirror Effect of Immunovative Therapies: A new approach to cancer treatment

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd, a biotech company in Israel, describes a new and unique approach to cancer treatment.

20 Jul 2013

Device / Technology News

BD Saf-T-Intima Safety Integrated IV Catheter System gets European approval for subcutaneous infusion therapy

MUCMD Symposium to be held at The Saban Research Institute of Children's Hospital Los Angeles

NYCEDC declares Innovate Health Tech NYC winners

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Novaliq receives CE mark approval for EyeSol technology

New version of RaySearch's RayStation treatment planning system released for clinical use

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Great Lakes NeuroTechnologies receives patent for Parkinson’s disease monitoring technology

Fujikura to exercise option to license Cellmid’s midkine diagnostic technology

HistoGenetics selects MiSeq sequencing system from Illumina for use in CLIA laboratory

Toshiba, Unfors RaySafe partner to improve clinical staff safety during interventional procedures

Cochlear implants restore usable hearing to deaf patients

EHR enables physicians to assist patients faster, help combat vaccine-preventable diseases

Kala Pharmaceuticals to present preclinical data on mucosal-penetrating particle technology

CETSA helps scientists determine effectiveness of drugs in the body

HealthTrust renews contract with McKesson Automation for pharmacy automation solutions

Cook Medical launches Biodesign ENT Repair Graft for rhinologists

Boston Scientific initiates OPTIMISE trial to study ONS using Precision System for chronic migraine

Pi2 Solutions introduces Drug Safety Triager application in UK

Mirror Effect of Immunovative Therapies: A new approach to cancer treatment

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News